List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Nordic Regulatory Affairs Market, By Countries, 2016-2028 (USD Million)
Table 4 Nordic Regulatory Affairs Market, By Service, 2016-2028 (USD Million)
Table 5 Nordic Regulatory Affairs Market, By Service provider, 2016-2028 (USD Million)
Table 6 Nordic Regulatory Affairs Market, By Company size, 2016-2028 (USD Million)
Table 7 Nordic Regulatory Affairs Market, By Category, 2016-2028 (USD Million)
Table 8 Nordic Regulatory Affairs Market, By Drugs, 2016-2028 (USD Million)
Table 9 Nordic Regulatory Affairs Market, By Innovator, 2016-2028 (USD Million)
Table 10 Nordic Regulatory Affairs Market, By Generics, 2016-2028 (USD Million)
Table 11 Nordic Regulatory Affairs Market, By Biologics, 2016-2028 (USD Million)
Table 12 Nordic Regulatory Affairs Market, By Biotech, 2016-2028 (USD Million)
Table 13 Nordic Regulatory Affairs Market, By ATMP, 2016-2028 (USD Million)
Table 14 Nordic Regulatory Affairs Market, By Biosimilar, 2016-2028 (USD Million)
Table 15 Nordic Regulatory Affairs Market, By Medical Devices, 2016-2028 (USD Million)
Table 16 Nordic Regulatory Affairs Market, By Diagnostics, 2016-2028 (USD Million)
Table 17 Nordic Regulatory Affairs Market, By Therapeutics, 2016-2028 (USD Million)
Table 18 Nordic Regulatory Affairs Market, By Stage, 2016-2028 (USD Million)
Table 19 Nordic Regulatory Affairs Market, By Indication, 2016-2028 (USD Million)
Table 20 Nordic Regulatory Affairs Market, By End Use, 2016-2028 (USD Million)
Table 21 Sweden Regulatory Affairs Market, By Service, 2016-2028 (USD Million)
Table 22 Sweden Regulatory Affairs Market, By Service provider, 2016-2028 (USD Million)
Table 23 Sweden Regulatory Affairs Market, By Company size, 2016-2028 (USD Million)
Table 24 Sweden Regulatory Affairs Market, By Category, 2016-2028 (USD Million)
Table 25 Sweden Regulatory Affairs Market, By Drugs, 2016-2028 (USD Million)
Table 26 Sweden Regulatory Affairs Market, By Innovator, 2016-2028 (USD Million)
Table 27 Sweden Regulatory Affairs Market, By Generics, 2016-2028 (USD Million)
Table 28 Sweden Regulatory Affairs Market, By Biologics, 2016-2028 (USD Million)
Table 29 Sweden Regulatory Affairs Market, By Biotech, 2016-2028 (USD Million)
Table 30 Sweden Regulatory Affairs Market, By ATMP, 2016-2028 (USD Million)
Table 31 Sweden Regulatory Affairs Market, By Biosimilar, 2016-2028 (USD Million)
Table 32 Sweden Regulatory Affairs Market, By Medical Devices, 2016-2028 (USD Million)
Table 33 Sweden Regulatory Affairs Market, By Diagnostics, 2016-2028 (USD Million)
Table 34 Sweden Regulatory Affairs Market, By Therapeutics, 2016-2028 (USD Million)
Table 35 Sweden Regulatory Affairs Market, By Stage, 2016-2028 (USD Million)
Table 36 Sweden Regulatory Affairs Market, By Indication, 2016-2028 (USD Million)
Table 37 Sweden Regulatory Affairs Market, By End Use, 2016-2028 (USD Million)
Table 38 Norway Regulatory Affairs Market, By Service, 2016-2028 (USD Million)
Table 39 Norway Regulatory Affairs Market, By Service provider, 2016-2028 (USD Million)
Table 40 Norway Regulatory Affairs Market, By Company size, 2016-2028 (USD Million)
Table 41 Norway Regulatory Affairs Market, By Category, 2016-2028 (USD Million)
Table 42 Norway Regulatory Affairs Market, By Drugs, 2016-2028 (USD Million)
Table 43 Norway Regulatory Affairs Market, By Innovator, 2016-2028 (USD Million)
Table 44 Norway Regulatory Affairs Market, By Generics, 2016-2028 (USD Million)
Table 45 Norway Regulatory Affairs Market, By Biologics, 2016-2028 (USD Million)
Table 46 Norway Regulatory Affairs Market, By Biotech, 2016-2028 (USD Million)
Table 47 Norway Regulatory Affairs Market, By ATMP, 2016-2028 (USD Million)
Table 48 Norway Regulatory Affairs Market, By Biosimilar, 2016-2028 (USD Million)
Table 49 Norway Regulatory Affairs Market, By Medical Devices, 2016-2028 (USD Million)
Table 50 Norway Regulatory Affairs Market, By Diagnostics, 2016-2028 (USD Million)
Table 51 Norway Regulatory Affairs Market, By Therapeutics, 2016-2028 (USD Million)
Table 52 Norway Regulatory Affairs Market, By Stage, 2016-2028 (USD Million)
Table 53 Norway Regulatory Affairs Market, By Indication, 2016-2028 (USD Million)
Table 54 Norway Regulatory Affairs Market, By End Use, 2016-2028 (USD Million)
Table 55 Denmark Regulatory Affairs Market, By Service, 2016-2028 (USD Million)
Table 56 Denmark Regulatory Affairs Market, By Service provider, 2016-2028 (USD Million)
Table 57 Denmark Regulatory Affairs Market, By Company size, 2016-2028 (USD Million)
Table 58 Denmark Regulatory Affairs Market, By Category, 2016-2028 (USD Million)
Table 59 Denmark Regulatory Affairs Market, By Drugs, 2016-2028 (USD Million)
Table 60 Denmark Regulatory Affairs Market, By Innovator, 2016-2028 (USD Million)
Table 61 Denmark Regulatory Affairs Market, By Generics, 2016-2028 (USD Million)
Table 62 Denmark Regulatory Affairs Market, By Biologics, 2016-2028 (USD Million)
Table 63 Denmark Regulatory Affairs Market, By Biotech, 2016-2028 (USD Million)
Table 64 Denmark Regulatory Affairs Market, By ATMP, 2016-2028 (USD Million)
Table 65 Denmark Regulatory Affairs Market, By Biosimilar, 2016-2028 (USD Million)
Table 66 Denmark Regulatory Affairs Market, By Medical Devices, 2016-2028 (USD Million)
Table 67 Denmark Regulatory Affairs Market, By Diagnostics, 2016-2028 (USD Million)
Table 68 Denmark Regulatory Affairs Market, By Therapeutics, 2016-2028 (USD Million)
Table 69 Denmark Regulatory Affairs Market, By Stage, 2016-2028 (USD Million)
Table 70 Denmark Regulatory Affairs Market, By Indication, 2016-2028 (USD Million)
Table 71 Denmark Regulatory Affairs Market, By End Use, 2016-2028 (USD Million)
Table 72 Finland Regulatory Affairs Market, By Countries, 2016-2028 (USD Million)
Table 73 Finland Regulatory Affairs Market, By Service, 2016-2028 (USD Million)
Table 74 Finland Regulatory Affairs Market, By Service provider, 2016-2028 (USD Million)
Table 75 Finland Regulatory Affairs Market, By Company size, 2016-2028 (USD Million)
Table 76 Finland Regulatory Affairs Market, By Category, 2016-2028 (USD Million)
Table 77 Finland Regulatory Affairs Market, By Drugs, 2016-2028 (USD Million)
Table 78 Finland Regulatory Affairs Market, By Innovator, 2016-2028 (USD Million)
Table 79 Finland Regulatory Affairs Market, By Generics, 2016-2028 (USD Million)
Table 80 Finland Regulatory Affairs Market, By Biologics, 2016-2028 (USD Million)
Table 81 Finland Regulatory Affairs Market, By Biotech, 2016-2028 (USD Million)
Table 82 Finland Regulatory Affairs Market, By ATMP, 2016-2028 (USD Million)
Table 83 Finland Regulatory Affairs Market, By Biosimilar, 2016-2028 (USD Million)
Table 84 Finland Regulatory Affairs Market, By Medical Devices, 2016-2028 (USD Million)
Table 85 Finland Regulatory Affairs Market, By Diagnostics, 2016-2028 (USD Million)
Table 86 Finland Regulatory Affairs Market, By Therapeutics, 2016-2028 (USD Million)
Table 87 Finland Regulatory Affairs Market, By Stage, 2016-2028 (USD Million)
Table 88 Finland Regulatory Affairs Market, By Indication, 2016-2028 (USD Million)
Table 89 Finland Regulatory Affairs Market, By End Use, 2016-2028 (USD Million)
Table 90 Iceland Regulatory Affairs Market, By Service, 2016-2028 (USD Million)
Table 91 Iceland Regulatory Affairs Market, By Service provider, 2016-2028 (USD Million)
Table 92 Iceland Regulatory Affairs Market, By Company size, 2016-2028 (USD Million)
Table 93 Iceland Regulatory Affairs Market, By Category, 2016-2028 (USD Million)
Table 94 Iceland Regulatory Affairs Market, By Drugs, 2016-2028 (USD Million)
Table 95 Iceland Regulatory Affairs Market, By Innovator, 2016-2028 (USD Million)
Table 96 Iceland Regulatory Affairs Market, By Generics, 2016-2028 (USD Million)
Table 97 Iceland Regulatory Affairs Market, By Biologics, 2016-2028 (USD Million)
Table 98 Iceland Regulatory Affairs Market, By Biotech, 2016-2028 (USD Million)
Table 99 Iceland Regulatory Affairs Market, By ATMP, 2016-2028 (USD Million)
Table 100 Iceland Regulatory Affairs Market, By Biosimilar, 2016-2028 (USD Million)
Table 101 Iceland Regulatory Affairs Market, By Medical Devices, 2016-2028 (USD Million)
Table 102 Iceland Regulatory Affairs Market, By Diagnostics, 2016-2028 (USD Million)
Table 103 Iceland Regulatory Affairs Market, By Therapeutics, 2016-2028 (USD Million)
Table 104 Iceland Regulatory Affairs Market, By Stage, 2016-2028 (USD Million)
Table 105 Iceland Regulatory Affairs Market, By Indication, 2016-2028 (USD Million)
Table 106 Iceland Regulatory Affairs Market, By End Use, 2016-2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Nordic regulatory affairs market snapshot (2020)
Fig. 9 Nordic regulatory affairs market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Personalized medicine as a percentage of CDER approved novel molecules.
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 SWOT
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Nordic regulatory affairs market service outlook: Segment dashboard
Fig. 18 Nordic regulatory affairs market: service movement analysis
Fig. 19 Regulatory consulting market, 2016-2028 (USD Million)
Fig. 20 Legal representation market, 2016-2028 (USD Million)
Fig. 21 Regulatory writing and publishing market, 2016-2028 (USD Million)
Fig. 22 Product registration and clinical trial applications market, 2016-2028 (USD Million)
Fig. 23 Other regulatory services market, 2016-2028 (USD Million)
Fig. 24 Nordic regulatory affairs market service provider outlook: Segment dashboard
Fig. 25 Nordic regulatory affairs market: Service provider movement analysis
Fig. 26 In-house regulatory affairs market, 2016-2028 (USD Million)
Fig. 27 Outsourcing regulatory affairs market, 2016-2028 (USD Million)
Fig. 28 Nordic regulatory affairs market company size outlook: Segment dashboard
Fig. 29 Nordic regulatory affairs market: Company Size movement analysis
Fig. 30 Small-sized companies based regulatory affairs market, 2016-2028 (USD Million)
Fig. 31 Medium-sized companies based regulatory affairs market, 2016-2028 (USD Million)
Fig. 32 Large-sized companies based regulatory affairs market, 2016-2028 (USD Million)
Fig. 33 Nordic regulatory affairs market category outlook: Segment dashboard
Fig. 34 Nordic regulatory affairs market: Category movement analysis
Fig. 35 Drugs-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 36 Biologics-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 37 Medical devices-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 38 Nordic regulatory affairs product stage outlook: Segment dashboard
Fig. 39 Nordic regulatory affairs market: Product Stage movement analysis
Fig. 40 Preclinical-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 41 Clinical studies-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 42 PMA-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 43 Nordic regulatory affairs market indication outlook: Segment dashboard
Fig. 44 Nordic regulatory affairs market: indication movement analysis
Fig. 45 Oncology-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 46 Neurology-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 47 Cardiology-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 48 Immunology-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 49 Other indication-based regulatory affairs market, 2016-2028 (USD Million)
Fig. 50 Nordic regulatory affairs market end-use outlook: Segment dashboard
Fig. 51 Nordic regulatory affairs market: end-use movement analysis
Fig. 52 Medical device companies market, 2016-2028 (USD Million)
Fig. 53 Pharmaceutical companies market, 2016-2028 (USD Million)
Fig. 54 Biotechnology companies market, 2016-2028 (USD Million)
Fig. 55 Country outlook, 2020 & 2028
Fig. 56 Nordic market, 2016-2028 (USD Million)
Fig. 57 Norway market, 2016-2028 (USD Million)
Fig. 58 Denmark market, 2016-2028 (USD Million)
Fig. 59 Sweden market, 2016-2028 (USD Million)
Fig. 60 Iceland market, 2016-2028 (USD Million)
Fig. 61 Finland market, 2016-2028 (USD Million)
Fig. 62 Organization structure-RegSmart Life Science AB
Fig. 63 SWOT-RegSmart Life Science AB
Fig. 64 Organization structure-Pharm Assist Sweden AB
Fig. 65 SWOT-Pharm Assist Sweden AB
Fig. 66 Organization structure-Genpact
Fig. 67 SWOT-Genpact
Fig. 68 Organization structure-Charles River Laboratories International, Inc.
Fig. 69 SWOT-Charles River Laboratories International, Inc.
Fig. 70 Organization structure-ICON plc
Fig. 71 SWOT-ICON plc
Fig. 72 Organization structure-PAREXEL International Corporation
Fig. 73 SWOT-PAREXEL International Corporation
Fig. 74 Organization structure-Freyr
Fig. 75 SWOT-Freyr
Fig. 76 Organization structure-Accell Clinical Research, LLC
Fig. 77 SWOT-Accell Clinical Research, LLC
Fig. 78 Organization structure-PRA Health Sciences
Fig. 79 SWOT-PRA Health Sciences
Fig. 80 Organization structure-Global Pharma Consulting AB
Fig. 81 SWOT-Global Pharma Consulting AB